Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity [0.03%]
肥胖人群用于 primary prevention of cardiovascular disease 的 Tirzepatide 使用三年对预测心血管疾病十年风险的降低作用
Naveed Sattar,Mamas Mamas,Runjia Li et al.
Naveed Sattar et al.
Aim: This post hoc analysis assessed the durability of tirzepatide for primary cardiovascular disease (CVD) prevention in obesity, based on predicted CVD risk, in the SURMOUNT-1 (SM-1) 3-year study. ...
When cardiometabolic risk meets myocardial vulnerability in the female heart [0.03%]
心血管代谢危险因素与女性心脏肌体脆弱性之间的关系
Jennifer H Mieres,Kumar Sarkar,Amgad N Makaryus
Jennifer H Mieres
Heart Failure Prevention in Central Adiposity and Preclinical Left Ventricular Systolic Impairment [0.03%]
中央型肥胖和左心室收缩功能不全前心力衰竭的预防
Matthew M Y Lee,Carolyn S P Lam
Matthew M Y Lee
Body mass index and major cardiovascular events after myocardial infarction: A nationwide registry study [0.03%]
体质指数与心肌梗死后主要心血管事件的关系:一项基于全国登记数据的研究
Peder Af Geijerstam,Pontus Hedberg,Nermin Hadziosmanovic et al.
Peder Af Geijerstam et al.
Aim: The "obesity paradox" suggests lower cardiovascular risk at higher body mass index (BMI) after myocardial infarction (MI), but whether it reflects true protection or methodological bias is unclear. ...
Rethinking how we characterize the exercise blood pressure response in athletes [0.03%]
重新考虑我们对运动员运动血压反应的特征方法
Gabriel S Romano,Natalie Miners,Philip J Millar
Gabriel S Romano
From Selye to ZEUS: inflammation as the adaptation syndrome's hidden machinery [0.03%]
从塞莱到ZEUS:炎症作为适应综合征的隐藏机器
Emilton Lima Junior,Fabiola Welter Ribeiro
Emilton Lima Junior
The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention [0.03%]
脂蛋白(a)在早发性心血管疾病中的作用:预防策略蓄势待发
Maya S Safarova,Laurence Sperling,Anurag Mehta et al.
Maya S Safarova et al.
Elevated Lp(a) is an independent, causal, genetic cardiovascular disease risk factor that is associated with the progression of high-risk coronary plaques. Risk of atherosclerotic cardiovascular disease (ASCVD)-related conditions, which are...
From Risk Stratification to Individualized Cardiac Rehabilitation: Expanding the Role of Physical Performance Assessment After Myocardial Infarction [0.03%]
从风险分层到个体化心脏康复:心肌梗死后物理表现评估角色的扩展
Akihiro Ogawa,Kanzaki Shinya,Shimizu Kazuhiro
Akihiro Ogawa
Ilham Benzidia,Victor Aboyans
Ilham Benzidia